Wired
•Sickle cell disease and beta-thalassemia are painful, lifelong conditions that in some cases can be fatal
65% Informative
Casgevy is meant to restore working hemoglobin in the body.
In sickle cell disease, abnormal hemoglobin makes a person’s blood cells hard and crescent-shaped.
In beta thalassemia patients, 39 did not need a blood transfusion for at least a year after treatment. US Vertex Cris every three to five weeks span class="summaryFeed_highLightText__NxlGi">Vertex only about 20 percent Julian Beach lGi">years Cri UK r Thursday s Casgevy ryFeed_highLightText__NxlGi">70 percent three at least a year 39 Crispr LightText__NxlGi">42 Casgevy 54 at least a year a month yFeed_highLightText__NxlGi">28 at least 18 months Vertex xt__N Crispr Therapeutics > 45 span class="summaryFeed_highLightText__NxlGi">Casgevy
VR Score
71
Informative language
79
Neutral language
37
Article tone
semi-formal
Language
English
Language complexity
42
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links